Harga Saham
24.14
Perubahan Harian
0.16 0.67%
Bulanan
-7.79%
Tahunan
-0.66%
Q2 Perkiraan
23.85




Biaya Operasional Perubahan Tanggal
argenx SE USD 914.57M 137.58M 2025-12
AstraZeneca USD 8.18B 4.35B 2026-03
Biogen USD 1.96B 69.6M 2026-03
Genmab DKK 798M 235M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GRIFOLS EUR 1.71B 193M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Incyte USD 5.62B 4.5B 2026-03
Merck EUR 4.78B 669M 2025-12
Neurocrine Biosciences USD 577.6M 22M 2025-12
Novartis USD 9.8B 61M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
UCB EUR 2.96B 196M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12